Updated Jul 16, 2026
Alfieri Michael is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $20K.
Michael Alfieri is the Principal Financial Officer at Aldeyra Therapeutics, Inc., a biotechnology company focused on developing medicines for immune-mediated and metabolic diseases. He has been involved in the financial operations of the company, contributing to its strategic initiatives.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-19 | ALDX | Aldeyra Therapeutics, Inc. | P — Open-market purchase | 5.0K | $1.42 | $7K |
| 2025-08-13 | ALDX | Aldeyra Therapeutics, Inc. | P — Open-market purchase | 2.5K | $5.30 | $13K |
Michael Alfieri is the Principal Financial Officer at Aldeyra Therapeutics, Inc., a biotechnology company focused on developing medicines for immune-mediated and metabolic diseases. He has been involved in the financial operations of the company, contributing to its strategic initiatives.…
Recorded transactions: 2 open-market purchases ($20K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Alfieri Michael profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.